Apollomics Inc. Class A Ordinary Shares Cash Flow Conversion Efficiency

Latest as of March 2025: -2.622x

Apollomics Inc. Class A Ordinary Shares cash flow conversion efficiency. Based on the latest financial reports, Apollomics Inc. Class A Ordinary Shares (APLM) has a cash flow conversion efficiency ratio of -2.622x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-12.76 Million) by net assets ($4.86 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Apollomics Inc. Class A Ordinary Shares (2019–2025)

Cash flow conversion efficiency of Apollomics Inc. Class A Ordinary Shares from 2019 to 2025. This chart illustrates how Apollomics Inc. Class A Ordinary Shares's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Apollomics Inc. Class A Ordinary Shares (APLM) share price today for real-time trading data and today's change.

Apollomics Inc. Class A Ordinary Shares Cash Flow Conversion Ratio Explained

Apollomics Inc. Class A Ordinary Shares cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Apollomics Inc. Class A Ordinary Shares Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Apollomics Inc. Class A Ordinary Shares ranked by their cash flow conversion efficiency. Also see Apollomics Inc. Class A Ordinary Shares market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Molinos Juan Semino SA
BA:SEMI
0.001x
Malin Corporation plc
IR:MLC
-0.004x
Alakasa Industrindo Tbk
JK:ALKA
0.034x
WebCash Corporation
KQ:053580
0.049x
E&E Recycling
TWO:8440
0.114x
Scanwolf Corporation Bhd
KLSE:7239
0.630x
KCP Sugar and Industries Corporation Limited
NSE:KCPSUGIND
0.089x
JAS Asset PCL
BK:J
0.016x

Annual Cash Flow Conversion Efficiency for Apollomics Inc. Class A Ordinary Shares (2019–2025)

The table below shows the annual cash flow conversion efficiency of Apollomics Inc. Class A Ordinary Shares from 2019 to 2025. Review Apollomics Inc. Class A Ordinary Shares free cash flow to debt ratio to assess the company's free cash flow relative to its total liabilities.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $-3.19 Million $-10.37 Million 3.253x +155.04%
2024-12-31 $4.86 Million $-28.74 Million -5.909x -463.92%
2023-12-31 $41.23 Million $-43.21 Million -1.048x -1196.54%
2022-12-31 $-448.12 Million $-42.82 Million 0.096x -53.03%
2021-12-31 $-212.86 Million $-43.31 Million 0.203x -27.04%
2020-12-31 $-127.93 Million $-35.68 Million 0.279x -22.82%
2019-12-31 $-60.72 Million $-21.94 Million 0.361x --

About Apollomics Inc. Class A Ordinary Shares

NASDAQ:APLM USA Biotechnology
Market Cap
$45.77 Million
Market Cap Rank
#23560 Global
#5131 in USA
Share Price
$20.84
Change (1 day)
+0.72%
52-Week Range
$12.16 - $28.01
All Time High
$2940.00
About

Apollomics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. The company's products portfolio includes Vebreltinib (APL-101), an oral active, highly selective c-Met inhibitor, which is in Phase 2 clinical trials for treatment of non-small cell lung… Read more